Is BioAtla, Inc. (BCAB) a Buy, Sell, or Hold?
NASDAQ : BCAB
BioAtla, Inc. — Competitors
$3.46 USD
$0.13 (3.9%)
- Volume
- 36.74K
- Average Volume
- 48.92K
- Market Capitalization
- $5.74M
- P/E Ratio
- -0.08
- Dividend Yield
- 0.00%
- Price Target
- $250.00
- Year High
- $71.50
- Year Low
- $3.12
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.15
BCAB vs. The Competition
| Properties | BCAB | ANVS | BTAI | CELU |
|---|---|---|---|---|
| Market Cap | $5.74M | $36.99M | $27.84M | $20.28M |
| Shares Outstanding | $1.66M | $19.67M | $30.88M | $28.95M |
| P/E Ratio | -0.08 | -1.09 | -0.13 | -0.19 |
| EPS | -33.71 | -1.47 | -6.17 | -3.58 |
| Day Low | 3.46 | 1.85 | 0.9017 | 0.6897 |
| Day High | 3.7083 | 1.945 | 0.92 | 0.7325 |
| Year Low | 3.12 | 1.54 | 0.737 | 0.56 |
| Year High | 71.5 | 5.5 | 8.08 | 4.31 |
| Average Price 50 | 3.6585 | 1.8028 | 1.0505 | 0.76152 |
| Average Price 200 | 15.13323 | 2.50195 | 1.47038 | 1.20941 |
| Volume | 36738 | 535.49K | 521.16K | 17491 |
| Average Volume | - | - | - | - |